Previous close | 1.9300 |
Open | 2.9500 |
Bid | 3.2100 x 3100 |
Ask | 3.2400 x 1300 |
Day's range | 2.8200 - 4.7600 |
52-week range | 1.4200 - 10.8800 |
Volume | |
Avg. volume | 3,089,452 |
Market cap | 172.89M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -14.8500 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.00 |
Q1 2024 Emergent BioSolutions Inc Earnings Call
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone. I’m […]
Emergent BioSolutions Inc (EBS) showcases robust revenue growth and operational efficiency in the first quarter of 2024.